This federal contract award, valued at $1,258.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of ENVARSUS XR 1 MG TABLET 100S, a specialty pharmaceutical product, to support military healthcare programs.
The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 8, 2025. It is not designated as a set-aside contract, indicating open competition.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/17/25, 10:01 AM